Miao Zhang

机构：Harbin Medical University, Heilongjiang University of Chinese Medicine, Anhui Medical University, Peking University, Zhaotong University, Peking University Cancer Hospital, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Nanfang Hospital, Ten Chen Hospital, Second Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Anhui Medical University, Qilu Hospital of Shandong University, Dezhou University · ORCID：0000-0002-4421-7100

发表论文 17 篇 · 总被引 130 次 · h-index 5

代表论文

Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials (2024 · EClinicalMedicine · 被引 89)
Association between fast eating speed and metabolic dysfunction-associated steatotic liver disease: a multicenter cross-sectional study and meta-analysis (2024 · Nutrition and Diabetes · 被引 8)
External treatment of traditional Chinese medicine for cancer pain: A systematic review and network meta-analysis (2024 · Medicine · 被引 8)
FG-M108 plus nab-paclitaxel and gemcitabine (AG) as first-line (1L) treatment for patients with Claudin-18.2 (CLDN18.2) positive locally advanced unresectable or metastatic pancreatic cancer (PC): Preliminary results from the phase 1b study. (2024 · Journal of Clinical Oncology · 被引 5)
Claudin18.2 expression in pulmonary mucinous adenocarcinoma (2023 · Journal of Cancer Research and Clinical Oncology · 被引 5)
FG-M108 plus capecitabine and oxaliplatin (CAPOX) for ﬁrst-line treatment of CLDN18.2+/HER2- advanced gastric/gastroesophageal junction adenocarcinoma (GC): Update results of a phase I/II trial to determine RP2D. (2025 · Journal of Clinical Oncology · 被引 3)